What is the appropriate initial workup for delayed puberty in adolescent males?

Initial Workup for Delayed Puberty in Males

The initial workup for delayed puberty in males (defined as absence of testicular enlargement ≥4 mL by age 14 years) should include measurement of serum LH, FSH, and early morning testosterone (preferably by liquid chromatography-tandem mass spectroscopy), along with bone age radiography. 1

Defining Delayed Puberty

Delayed puberty in males is defined as:

• Absence of testicular growth to at least 4 mL in volume or 2.5 cm in length by age 14 years 2
• Testicular volume ≥4 mL marks the first pubertal increase; from 10 mL, daytime testosterone levels rise leading to virilization 3

Essential History and Physical Examination

Key Historical Elements to Obtain:

• Family history of delayed puberty (constitutional delay often familial) 4, 5
• Previous or current cancer treatment, particularly:
  • Hypothalamic-pituitary (HP) axis radiation ≥30 Gy 1
  • History of tumors or surgery affecting the HP axis region
  • Gonadotoxic treatments (alkylating agents, testicular radiotherapy) 1
• Chronic systemic diseases affecting growth and nutrition 6
• Anosmia (suggests Kallmann syndrome) 1
• Medication history, especially antipsychotics (can cause hyperprolactinemia) 1

Physical Examination Priorities:

• Testicular volume measurement (using orchidometer) 2
• Tanner staging of genital development 3
• Height and weight plotted on growth curves with calculation of growth velocity 2
• Midparental height calculation 7
• Body mass index (obesity/underweight affects hormone interpretation) 1
• Neurologic examination if central pathology suspected 2

Critical caveat: In males previously exposed to gonadotoxic treatments, testicular volume should NOT be used as the primary indicator of sexual development, as these agents cause primary testicular damage 1

Laboratory Workup

First-Line Hormonal Testing:

• Early morning (before 10:00 AM) serum testosterone using liquid chromatography-tandem mass spectroscopy 1
• LH and FSH levels 1, 2
• Bone age radiography (left hand and wrist) 2, 8

Interpretation Framework:

Low/undetectable testosterone with low or inappropriately normal LH/FSH = Hypogonadotropic hypogonadism (central/secondary) 1

Low testosterone with elevated LH/FSH = Hypergonadotropic hypogonadism (primary gonadal failure) 8, 9

Important consideration: Gonadotropin and sex hormone levels must be interpreted cautiously in obese or underweight individuals, as these conditions confound results 1

Additional Testing When Indicated:

If abnormal growth velocity is present:

• Thyroid function tests (TSH, free T4) 2
• Prolactin (hyperprolactinemia can cause hypogonadotropic hypogonadism) 1, 2
• IGF-I (to assess growth hormone status) 2

For cancer survivors specifically: The diagnosis of LH/FSH deficiency is complicated by nonspecific symptoms in males and the high prevalence of constitutional delay. However, exposure to HP axis radiation and presence of other pituitary deficiencies are robust indicators of true LH/FSH deficiency 1

When to Obtain Brain MRI

Brain MRI should be performed in:

• All boys with precocious puberty (different scenario but important differential) 2
• Boys with neurologic symptoms 2
• Childhood cancer survivors with HP axis radiation ≥30 Gy or tumors affecting the HP region 1
• Suspected central pathology based on history or examination

Differential Diagnosis Framework

The three main categories to distinguish:

1. Constitutional delay of growth and puberty (CDGP) - most common, accounting for ~60% of male cases 9
2. Permanent hypogonadotropic hypogonadism (congenital: Kallmann syndrome, pituitary stalk interruption, midline defects; acquired: tumors, radiation, surgery) 1, 9
3. Hypergonadotropic hypogonadism (primary gonadal failure) 8, 9

Key distinction: CDGP is a diagnosis of exclusion after ruling out pathologic causes 4, 5. Recent research suggests CDGP and congenital hypogonadotropic hypogonadism have distinct genetic profiles that may aid differential diagnosis 4

Common Pitfalls to Avoid

• Do not rely solely on testicular volume in boys exposed to gonadotoxic chemotherapy or testicular radiation - measure testosterone and LH directly 1
• Do not dismiss normal IGF-I levels in the setting of delayed bone age and pubertal delay - IGF-I should be interpreted in context of bone age and pubertal stage 7
• Do not forget to rule out hyperprolactinemia in suspected LH/FSH deficiency, as this is treatable 1
• Recognize that elevated LH in gonadotoxin-exposed patients may indicate primary gonadal injury rather than central puberty onset 1